TRT injections: what the pain science actually says
Quick answer
The video addresses self-administered testosterone injections, specifically the subcutaneous route using a 31-gauge, half-inch needle, which reflects a legitimate and increasingly common clinical approach for TRT delivery. Pain experience during self-injection is influenced by needle gauge, injection depth, oil vehicle, site rotation, and individual anatomy, none of which are fully addressed in the video. The promotional content for Hardly Meds does not constitute a medical consultation, and viewers considering TRT should confirm that any telehealth provider conducts baseline labs and ongoing monitoring per standard hypogonadism management guidelines.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @kmartfit actually say?
The claim is simple: TRT injections, done correctly, should be essentially painless. The creator points to small-gauge needles, specifically "a half-inch, 31-gauge needle," as the reason modern self-injection is a non-event. He also frames needle anxiety as a mental barrier rather than a legitimate concern, and closes with a pitch for a telehealth clinic called Hardly Meds.
To be fair, this is a practical, experience-based video, not a medical lecture. He is not prescribing doses or making wild efficacy claims. The core message is: the needle fear is worse than the needle itself. That part is worth examining honestly.
Does the science back this up?
Largely, yes, with some important caveats. Subcutaneous testosterone injections using fine-gauge needles do produce significantly less pain than older intramuscular protocols. The research supports the general direction of his argument.
A 2017 study by Olsson et al. in the Journal of Clinical Nursing found that needle gauge and insertion technique were the strongest predictors of injection-site pain across self-administered subcutaneous protocols. Thinner needles, shorter lengths, and consistent technique correlated with minimal discomfort. A 2019 study by Pastuszak et al. in Sexual Medicine confirmed that subcutaneous testosterone delivery was well-tolerated by patients, with low pain scores and high adherence rates. So the 31-gauge half-inch claim is not invented, it reflects a real shift in clinical practice toward smaller needles for subcutaneous administration.
What he glosses over: injection site reactions, post-injection pain from the oil vehicle itself, and individual variation in pain sensitivity. Some patients, particularly those injecting intramuscularly into the glute with older thicker needles, do report meaningful soreness for 24 to 48 hours.
What did they get wrong (or right)?
He got the needle technology part right. A 31-gauge needle is genuinely fine, close to what diabetics use for insulin. The claim that "you shouldn't even know that you did it" is plausible for subcutaneous injections with proper technique, and clinical data backs that up.
What he oversimplifies: the phrase "if you do a TRT injection properly" is doing a lot of work. Proper technique includes site rotation, correct depth based on body composition, avoiding scar tissue buildup, and understanding that the oil carrier, usually sesame or cottonseed oil, can cause delayed soreness regardless of needle size. He does not mention any of this.
He also implies the pain experience is universal. It is not. Patients with lipodystrophy, certain body fat distributions, or injection anxiety can have meaningfully different experiences. Saying "the answer should be no" without qualification sets an expectation that may not match reality for everyone.
The promotional close for Hardly Meds is transparent, at least. He names the clinic directly rather than burying it in a bio link. That does not make it a medical recommendation, but the disclosure is clearer than most affiliate-style TikTok content in this space.
What should you actually know?
If you are considering TRT and needle anxiety is a real barrier, here is what the evidence actually says. Subcutaneous injections with fine-gauge needles are a validated, low-pain option that many patients tolerate well. This is not influencer optimism, it is reflected in clinical practice guidelines and patient adherence data.
However, pain is only one variable. Injection site reactions, oil vehicle sensitivity, and technique errors can all cause discomfort that has nothing to do with needle size. A legitimate clinic should walk you through technique, not just hand you a syringe.
Needle phobia, formally classified as trypanophobia, affects roughly 25 percent of adults to some degree, according to McLenon and Rogers, 2019, in the Journal of Advanced Nursing. Framing it as a "mental hurdle" is not wrong, but it undersells what can be a genuine physiological stress response for some people. Cognitive behavioral approaches and gradual exposure are evidence-based strategies for needle anxiety, not just willpower.
If you are exploring TRT through any telehealth provider, ask specifically which delivery method and needle gauge their protocols use, whether a licensed provider reviews your labs, and what the follow-up monitoring schedule looks like.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT injections: what the pain science actually says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT injections: what the pain science actually says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The video addresses self-administered testosterone injections, specifically the subcutaneous route using a 31-gauge, half-inch needle, which reflects a legitimate and increasingly common clinical approach for TRT delivery.
FormBlends verdict
The video addresses self-administered testosterone injections, specifically the subcutaneous route using a 31-gauge, half-inch needle, which reflects a legitimate and increasingly common clinical approach for TRT delivery. Pain experience during self-injection is influenced by needle gauge, injection depth, oil vehicle, site rotation, and individual anatomy, none of which are fully addressed in the video. The promotional content for Hardly Meds does not constitute a medical consultation, and viewers considering TRT should confirm that any telehealth provider conducts baseline labs and ongoing monitoring per standard hypogonadism management guidelines.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video addresses self-administered testosterone injections, specifically the subcutaneous route using a 31-gauge, half-inch needle, which reflects a legitimate and increasingly common clinical approach for TRT delivery. Pain experience during self-injection is influenced by needle gauge, injection depth, oil vehicle, site rotation, and individual anatomy, none of which are fully addressed in the video. The promotional content for Hardly Meds does not constitute a medical consultation, and viewers considering TRT should confirm that any telehealth provider conducts baseline labs and ongoing monitoring per standard hypogonadism management guidelines.
- 31-gauge, half-inch needles are a real and validated option for subcutaneous testosterone injections, not marketing spin.
- Pastuszak et al. (2019, Sexual Medicine) found subcutaneous testosterone delivery had low pain scores and high patient adherence, supporting the core claim.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- 31-gauge, half-inch needles are a real and validated option for subcutaneous testosterone injections, not marketing spin.
- Pastuszak et al. (2019, Sexual Medicine) found subcutaneous testosterone delivery had low pain scores and high patient adherence, supporting the core claim.
- Post-injection soreness lasting 24 to 48 hours can occur from the oil carrier vehicle, sesame or cottonseed oil, regardless of needle size, and the video does not mention this.
- McLenon and Rogers (2019, Journal of Advanced Nursing) found roughly 25 percent of adults have meaningful needle anxiety, which can involve physiological responses, not just a mental block.
- Broad claims that TRT will make you feel amazing are not supported by evidence for all patients. Snyder et al. (2016, NEJM) showed benefits were most pronounced in men with confirmed hypogonadism and specific symptoms.
- Any TRT provider, telehealth or in-person, should require baseline testosterone bloodwork and follow-up labs. Technique guidance for self-injection is part of responsible prescribing, not optional.
- The promotional disclosure for Hardly Meds is more transparent than typical affiliate content, but a TikTok comment thread is not a substitute for a clinical intake process.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
KMART · TikTok creator
7.9K views on this video
Does a TRT injection hurt? #testosteronetherapy #testosteronerepacementtherapy #trt #testosterone
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by KMART, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.